inōtiv Corporate Presentation June 2023 slide image

inōtiv Corporate Presentation June 2023

12 Successful Launch of New Services 8 Internally Developed Services and New Capabilities over past 2 years, enabling improved client experience, accelerating speed of development and testing, reducing outsourcing, and generating internal growth MP&T Juvenile Toxicology SEND Reporting Clinical Pathology Biotherapeutics Genetic Toxicology Safety Pharmacology Archiving Mechanistic Pharmacology and Toxicology Enhanced learning and memory behaviors Databases for regulatory review Expert interpretation of clinical pharmacology and toxicology data Support of large molecule biotherapeutics, biomarkers, and cell-based analysis and therapeutics Building capabilities to evaluate mutagenicity and clastogenicity in support of first-in- human dosing Large animal respiratory and cardiovascular safety pharmacology Centralized archival services for the presentative and management of regulated and non- regulated records and specimens to be launched Q2 FY2024 CORPORATE PRESENTATION inōtiv analyze, answer. advance.
View entire presentation